25
Participants
Start Date
November 16, 2018
Primary Completion Date
September 19, 2020
Study Completion Date
September 19, 2020
Insulin Degludec
Subjects will use Insulin Degludec (Tresiba) with TRESIBA® FLEXTOUCH® pens as their basal insulin during a 9-10 hour flight, at each destination, and then during a return flight.
Insulin Glargine
Subjects will use Insulin Glargine (Lantus) with LANTUS® SOLOSTAR® INSULIN PEN as their basal insulin during a 9-10 hour flight, at each destination, and then during a return flight.
TRESIBA® FLEXTOUCH®
Subjects will use Tresiba FlexTouch pens when using Tresiba as their basal insulin during a 9-10 hour flight, at each destination, and then during a return flight.
LANTUS® SOLOSTAR® INSULIN PEN
Subjects will use Lantus SoloStar insulin pens when using Lantus as their basal insulin during a 9-10 hour flight, at each destination, and then during a return flight.
Sansum Diabetes Research Institute, Santa Barbara
inControl Diabetes Center, Honolulu
Collaborators (1)
Novo Nordisk A/S
INDUSTRY
Sansum Diabetes Research Institute
OTHER